Data as of Aug 25, 2026 · Based on 1,299 AI responses · See how Parse measures this
Consumer Genomics Products and Services
Parse
https://parse.gl
23andMe remains the most frequently cited brand in AI responses for consumer genomics services. However, conversations are increasingly shifting toward specialized providers, with services like gaining prominence for actionable health insights and for its strong privacy stance.
| # | Brand | What AI says | Mention rate |
|---|---|---|---|
| 1 | The leading service, but often cited with concerns about data privacy and bankruptcy. | 31% | |
| 2 | A leading clinical software for creating pedigrees and managing family history data. | 20% | |
| 3 | A modern | 18% | |
| 4 | 18% | ||
| 5 | Stands out for AI-driven, actionable health reports that integrate labs and lifestyle data. | 17% | |
| 6 | 17% | ||
| 7 | 16% | ||
| 8 | A key telehealth provider for direct-to-consumer genetic counseling services. | 16% | |
| 9 | Cited for offering whole-genome sequencing for the most comprehensive genetic data. | 16% | |
| 10 | 15% | ||
| 11 | Mentioned often for providing direct telehealth genetic counseling for consumers. | 15% | |
| 12 | 14% | ||
| 13 | 13% | ||
| 14 | 13% | ||
| 15 | 12% | ||
| 16 | 12% | ||
| 17 | 11% | ||
| 18 | 10% | ||
| 19 | 10% | ||
| 20 | 10% | ||
| 21 | 10% | ||
| 22 | 9% | ||
| 23 | 8% | ||
| 24 | 8% | ||
| 25 | 8% |
Who wins on each AI
The same market, seen by two models.
Sources AI cited
reddit.com is the page AI reaches for most here, cited in 23% of analyzed answers.
“A default recommendation for genetic health information.” → “A service cited with increasing caveats about data privacy and its bankruptcy.”
Gained prominence after Nov 2025 for its AI-driven, personalized health reports.
Its mention share dropped from 77% in Oct 2025 to 53% in Mar 2026.
Emerged in Nov 2025 to become a top recommendation for its strong privacy stance.
| Brand | ChatGPT Search | Google AI Mode | Comparison |
|---|---|---|---|
| 38% | 36% | ||
| 23% | 19% | ||
| 13% | 21% | ||
| 14% | 19% | ||
| 22% | 0% |
The two models disagree most about TrakGene (ChatGPT #21, Google #2) and Online Mendelian Inheritance in Man (OMIM) (ChatGPT #25, Google #7).
23andMe remains the most frequently cited brand in AI responses for consumer genomics services. However, conversations are increasingly shifting toward specialized providers, with services like SelfDecode gaining prominence for actionable health insights and Sequencing.com for its strong privacy stance.
Across 1,299 AI responses, 23andMe is mentioned most, named in 31% of them, followed by Progeny Genetics (20%) and FamGenix (18%).
Parse measures each brand's mention rate — the share of answers naming it — across 1,299 AI responses to this market's buyer questions. Answers are collected daily and the ranking is published weekly.
Brands enter the ranking when AI answers mention them. Parse collects answers daily and publishes the re-measured set weekly, so new brands appear as AI starts recommending them.
AI responses have evolved, shifting focus from the general health reports of 23andMe to more specialized services. Since November 2025,
SelfDecode has been consistently highlighted for its AI-driven actionable recommendations, alongside
Nebula Genomics for its comprehensive whole-genome sequencing.
AI responses have evolved, shifting focus from the general health reports of 23andMe to more specialized services. Since November 2025,
SelfDecode has been consistently highlighted for its AI-driven actionable recommendations, alongside
Nebula Genomics for its comprehensive whole-genome sequencing.
AI responses consistently highlight companies with explicit 'no sell' privacy policies. Initially, and FamilyTreeDNA were key recommendations, but by late 2025, became a dominant suggestion for its strong privacy-first stance, frequently contrasted with the complex policies of larger companies like .
Brands mentioned
AI responses consistently highlight companies with explicit 'no sell' privacy policies. Initially, MyHeritage and FamilyTreeDNA were key recommendations, but by late 2025,
Sequencing.com became a dominant suggestion for its strong privacy-first stance, frequently contrasted with the complex policies of larger companies like
23andMe.